/
ASBP
$6.14+$0.14 (+2.33%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$7.8M
1M shares
52-week range
$3.31 – $1,050.36
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
144.38%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-7385.86
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $6.2K |
| Cost of revenue | $0 | $0 | $0 | $0 | $6.3K |
| Gross profit | $0 | $0 | $0 | $0 | −$116 |
| Gross margin | — | — | — | — | -1.9% |
| R&D | $0 | $175.3K | $72.0K | $144.4K | $923.9K |
| Operating income | −$25.5K | −$976.3K | −$1.3M | −$3.1M | −$19.4M |
| EBITDA | −$25.5K | $3.3M | $5.8M | −$11.6M | −$11.3M |
| Net income | −$25.5K | $3.3M | $4.5M | −$12.5M | −$24.5M |
| Net margin | — | — | — | — | -394725.1% |
| EPS (diluted) | -0.04 | 3.72 | 9.31 | -18.17 | -16.38 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Aspire Biopharma Holdings, Inc. Common Stock
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
www.aspirebiolabs.com- IPO / List date
- Feb 20, 2025
- HQ
- ESTERO, FL
Held by traders on TradeandTell
No one on the platform currently holds ASBP.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ASBP as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-11 | 1-for-30reverse |
| 2026-01-16 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded ASBP yet.
